Healthcare Industry News: imaging agent
News Release - November 19, 2007
Covidien Signs Contrast Imaging Agent Agreement with MedAssets Supply Chain Systems
Contract expands on contrast delivery system agreement signed earlier this yearST. LOUIS--(HSMN NewsFeed)--Covidien Ltd. (NYSE: COV, BSX: COV) today announced that one of its subsidiaries has signed a new agreement to supply X-ray contrast imaging agents to customers of MedAssets Supply Chain Systems, a St. Louis-based group purchasing organization. The multi-year agreement broadens the scope of Covidien Imaging Solutions products available to MedAssets Supply Chain Systems customers nationwide.
Under the agreement, which became effective on November 1, Covidien will provide a range of products used to aid in the diagnosis of disease including X-ray contrast agents, sodium chloride injection, USP 0.9% in Ultraject™ prefilled syringes and MD-Gastroview™ (diatrizoate meglumine and diatrizoate sodium solution, USP). Covidien Imaging Solutions also is supplying its full portfolio of contrast media injectors to MedAssets’ customers in accordance with a separate agreement signed earlier this year.
“This agreement enables us to collaborate with MedAssets Supply Chain Systems and its customers to provide world-class imaging products and novel delivery systems that are instrumental in the diagnosis of disease,” said Rick Lytle, Vice President and General Manager of Imaging – U.S. “Now, MedAssets’ customers will be able to use our contrast imaging agents in combination with our injectors to more efficiently meet the needs of the healthcare provider and patient.”
The Covidien Imaging Solutions segment, which is also based in St. Louis, is a leading supplier of contrast media products. It offers the only fully integrated contrast delivery system complete with contrast imaging agents, prefilled sodium chloride syringes and contrast media injectors. MedAssets Supply Chain Systems is one of the largest group purchasing organizations in the U.S.
“We are pleased to be expanding our relationship with Covidien Imaging Solutions, with whom we share a common focus on helping healthcare providers and patients,” said Jerry Allen, Executive Director, Imaging and Capital Services Program, MedAssets Supply Chain Systems. “This agreement aligns with our goal of working with innovative suppliers to deliver products and services that help our customers drive value and efficiency, while enhancing patient care.”
ABOUT COVIDIEN
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines, including Surgical Devices, Energy-based Devices, Respiratory and Monitoring Solutions, Patient Care and Safety Products, Imaging Solutions, Pharmaceutical Products, Medical Supplies and Retail Products. With 2006 revenue of nearly $10 billion, Covidien has more than 43,000 employees worldwide in 57 countries, and its products are sold in over 130 countries. Please visit www.covidien.com to learn more about our business.
ABOUT MEDASSETS
MedAssets partners with healthcare providers to improve their financial strength by implementing integrated spend management and revenue cycle solutions that help control cost, improve margins and cash flow, increase regulatory compliance, and optimize operational efficiency. MedAssets serves more than 125 health systems, including 2,500 hospitals and 30,000 non-acute care healthcare providers. For more information, go to www.medassets.com
COVIDIEN, COVIDIEN with Logo and ™ marked brands are trademarks of Covidien AG or its affiliate. © 2007 Covidien AG or its affiliate. All rights reserved.
Source: Covidien
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
